Return to top of page

Stakeholder Perspective on Sarcopenia Patient-Reported Outcome Measures

Published May 19, 2017

The Aging in Motion (AIM) Coalition presented the first in a series of biannual webinars on the future of research, therapeutic development, and treatment of sarcopenia. This one-hour webinar highlighted best practices from a successful public-private partnership qualifying Patient-Reported Outcome (PRO) measures in multiple therapeutic areas; explored diverse stakeholder perspectives on the role of PRO measures in supporting the regulatory assessment of sarcopenia treatments; and featured the relevance of PRO measures in capturing changes in mobility and improvements in quality of life for sarcopenic patients.

Learn more at